1H-magnetic resonance spectroscopy of the breast at 3.0-T: Comparison of results obtained before and after administration of gadolinium-based contrast agent

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 3, 2012, Pages 717-722

  Kawai, Hisashi ^a   Naganawa, Shinji ^a   Satake, Hiroko ^a   Ishigaki, Satoko ^a   Sakurai, Yasuo ^b   Mori, Minako ^b   Maruyama, Katsuya ^c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c Imaging and Therapy Systems Division   (Japan)

Author keywords

breast cancer; diffusion weighted image; gadolinium based contrast agent; MR spectroscopy

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; BREAST CANCER; CANCER ADJUVANT THERAPY; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY; REVIEW; VOXEL BASED MORPHOMETRY;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHOLINE; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 84857082112     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22893     Document Type: Review

References (31)

1. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989; 172: 541-548. (Pubitemid 19184903)
2. Berkelbach van der Sperenkel JW, Luyten PR, van Rijen PC, Tulleken CA, den Hollander JA,. Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction. Stroke 1988; 19: 1556-1560. (Pubitemid 19005814)
3. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58. (Pubitemid 24103384)
4. 1H MRS and MRI. Magn Reson Imaging 1997; 15: 1177-1186. (Pubitemid 27516466)
5. 1H MR spectroscopy. J Magn Reson Imaging 1999; 10: 159-164. (Pubitemid 29362430)
6. Yeung DK, Cheung HS, Tse GM,. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy-initial results. Radiology 2001; 220: 40-46. (Pubitemid 32577957)
7. Sardanelli F, Fausto A, DiLeo G, et al. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. AJR Am J Roentgenol 2009; 192: 1608-1617.
8. 1H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography. J Magn Reson Imaging 2008; 28: 420-427.
9. 1H MR Spectroscopy. Radiology 2009; 251: 653-662.
10. 1H MR spectroscopy. Magn Reson Med 2003; 50: 1134-1143. (Pubitemid 37494015)
11. 1H MRS at 1.5T. Eur Radiol 2005; 15: 1037-1043. (Pubitemid 41166737)
12. Tse GM, Cheung HS, Pang LM, et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 2003; 181: 1267-1272. (Pubitemid 37296401)
13. 1H) MR spectroscopy. Radiology 2007; 245: 80-87. (Pubitemid 47417790)
14. 1H MR spectroscopy and diffusion weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? AJR Am J Roentgenol 2009; 193: 840-849.
15. Jacobs MA, Barker PB, Argani P, Ouwerkerk R, Bhujwalla ZM, Bluemke DA,. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging 2005; 21: 23-28. (Pubitemid 40041416)
16. 1-weighted choline signal in human brain tumours. Magn Reson Imaging 2002; 20: 127-130. (Pubitemid 34309140)
17. 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. Magn Reson Imaging 1998; 16: 1273-1280. (Pubitemid 29019553)
18. Smith JK, Kwock L, Castillo M,. Effects of contrast material on single-volume proton MR spectroscopy. Am J Neuroradiol 2000; 21: 1084-1089. (Pubitemid 30390548)
19. 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration. Invest Radiol 2005; 40: 405-411. (Pubitemid 40863783)
20. Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996; 199: 391-401.
21. Okada Y, Ohtomo K, Kiryu S, Sasaki Y,. Breath-hold T2-weighted MRI of hepatic tumors: value of echo planar imaging with diffusion-sensitizing gradient. J Comput Assist Tomogr 1998; 22: 364-371. (Pubitemid 28396727)
22. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M,. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22: 275-282. (Pubitemid 39264807)
23. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumors: usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005; 29: 644-649. (Pubitemid 41395779)
24. Kuroki-suzuki S, Kuroki Y, Nasu K, Nawano S, Moriyama N, Okazaki M,. Detecting breast cancer with non-contrast MR imaging combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 2007; 6: 21-27.
25. Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD,. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 2010; 31: 562-570.
26. Yabuchi H, Matsuo Y, Sunami S, et al. Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol 2010; 21: 11-17.
27. Baltzer PA, Renz DM, Herrmann KH, et al. Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 2009; 19: 1612-1620.
28. Hu J, Feng W, Hua J, et al. A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging tecunique for the human breast at 3 T. Med Phys 2009; 36: 4870-4877.
29. Lenkinski RE, Wang X, Elian M, Goldberg SN,. Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast. Magn Reson Med 2009; 61: 1286-1292.
30. Kuhl CK, Jost P, Morakkabati N, Zivanovic O, Schild HH, Gieseke J,. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 2006; 239: 666-676. (Pubitemid 43830601)
31. 1 inhomogeneity on breast MR imaging at 3.0T. Radiology 2007; 244: 929-930. (Pubitemid 47292110)